CRANE NXT CO (CXT) Stock Fundamental Analysis

NYSE:CXT • US2244411052

53.835 USD
+0.59 (+1.1%)
Last: Feb 18, 2026, 12:34 PM
Fundamental Rating

5

Taking everything into account, CXT scores 5 out of 10 in our fundamental rating. CXT was compared to 122 industry peers in the Electronic Equipment, Instruments & Components industry. While CXT belongs to the best of the industry regarding profitability, there are concerns on its financial health. CXT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year CXT was profitable.
  • CXT had a positive operating cash flow in the past year.
  • CXT had positive earnings in each of the past 5 years.
  • In the past 5 years CXT always reported a positive cash flow from operatings.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • The Return On Assets of CXT (5.30%) is better than 72.13% of its industry peers.
  • CXT has a Return On Equity of 12.74%. This is amongst the best in the industry. CXT outperforms 80.33% of its industry peers.
  • With a decent Return On Invested Capital value of 8.78%, CXT is doing good in the industry, outperforming 78.69% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 8.80%.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.78%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • CXT has a Profit Margin of 9.80%. This is amongst the best in the industry. CXT outperforms 82.79% of its industry peers.
  • CXT's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 17.59%, CXT belongs to the best of the industry, outperforming 92.62% of the companies in the same industry.
  • CXT's Operating Margin has improved in the last couple of years.
  • CXT has a better Gross Margin (43.20%) than 75.41% of its industry peers.
  • CXT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
  • CXT has more shares outstanding than it did 1 year ago.
  • CXT has less shares outstanding than it did 5 years ago.
  • CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CXT has an Altman-Z score of 2.16. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.16, CXT is doing worse than 60.66% of the companies in the same industry.
  • The Debt to FCF ratio of CXT is 6.27, which is on the high side as it means it would take CXT, 6.27 years of fcf income to pay off all of its debts.
  • CXT's Debt to FCF ratio of 6.27 is in line compared to the rest of the industry. CXT outperforms 57.38% of its industry peers.
  • A Debt/Equity ratio of 0.89 indicates that CXT is somewhat dependend on debt financing.
  • CXT has a Debt to Equity ratio of 0.89. This is amonst the worse of the industry: CXT underperforms 86.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.16
ROIC/WACC0.93
WACC9.43%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that CXT should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.26, CXT is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
  • CXT has a Quick Ratio of 1.26. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CXT's Quick ratio of 0.94 is on the low side compared to the rest of the industry. CXT is outperformed by 80.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • The Earnings Per Share has been growing slightly by 1.12% on average over the past years.
  • CXT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.43%.
  • CXT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.71% yearly.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.53% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.26, CXT is valued correctly.
  • CXT's Price/Earnings ratio is rather cheap when compared to the industry. CXT is cheaper than 89.34% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CXT to the average of the S&P500 Index (27.16), we can say CXT is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.84, the valuation of CXT can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CXT is valued cheaper than 91.80% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.10. CXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.26
Fwd PE 11.84
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • CXT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CXT is cheaper than 90.16% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 85.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.91
EV/EBITDA 9.79
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CXT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.11
PEG (5Y)11.83
EPS Next 2Y11.53%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.30%, CXT has a reasonable but not impressive dividend return.
  • CXT's Dividend Yield is rather good when compared to the industry average which is at 0.47. CXT pays more dividend than 91.80% of the companies in the same industry.
  • CXT's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

  • On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
  • CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 24.82% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.82%
EPS Next 2Y11.53%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (2/18/2026, 12:34:04 PM)

53.835

+0.59 (+1.1%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners114.42%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change3.38%
Market Cap3.09B
Revenue(TTM)1.66B
Net Income(TTM)154.70M
Analysts81.82
Price Target94.28 (75.13%)
Short Float %12.64%
Short Ratio9.41
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.98%
EPS NY rev (1m)0.04%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 13.26
Fwd PE 11.84
P/S 1.96
P/FCF 17.91
P/OCF 14.26
P/B 2.55
P/tB N/A
EV/EBITDA 9.79
EPS(TTM)4.06
EY7.54%
EPS(NY)4.55
Fwd EY8.44%
FCF(TTM)3.01
FCFY5.58%
OCF(TTM)3.78
OCFY7.01%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)1.11
PEG (5Y)11.83
Graham Number43.95
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.78%
ROICexc 9.45%
ROICexgc 35.12%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
ROICexc(3y)12.73%
ROICexc(5y)12.19%
ROICexgc(3y)46.7%
ROICexgc(5y)44.71%
ROCE(3y)14.96%
ROCE(5y)14.57%
ROICexgc growth 3Y-23.13%
ROICexgc growth 5Y12.65%
ROICexc growth 3Y-18.15%
ROICexc growth 5Y5.03%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.16
F-Score4
WACC9.43%
ROIC/WACC0.93
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y-5.02%
EBIT growth 5Y-1.54%
EBIT Next Year23.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.61%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y2.51%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 2 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 6 / 10 and the dividend payout ratio is 24.82%.